The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis.
Ball S, Vickery J, Hobart J, Wright D, Green C, Shearer J, Nunn A, Cano M G, Macmanus D, Miller D, et al.
Health Technol Assess. 2015 Feb; 19(12):1-188. PMID: 25676540.Abstract